Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001247821 | SCV001421266 | pathogenic | Mucopolysaccharidosis type 1 | 2024-09-19 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 12 of the IDUA gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in IDUA are known to be pathogenic (PMID: 11735025, 21480867). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with MPS I (PMID: 22976768; internal data). ClinVar contains an entry for this variant (Variation ID: 557744). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV001784289 | SCV002023105 | pathogenic | not provided | 2020-04-22 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000673922 | SCV000799178 | likely pathogenic | Hurler syndrome | 2018-04-06 | no assertion criteria provided | clinical testing | This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. |